| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.055 | 0.4 |